Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease

Polskie Archiwum Medycyny Wewnetrznej

Volumn 122, Issue 6, 2012, Pages 284-290

  Ulasli, Sevinc S ^a   Ozyurek, Berna A ^b   Yilmaz, Eylul B ^b   Ulubay, Gaye ^b  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Acute phase reactant; Chronic obstructive pulmonary disease; Exacerbation; Mean platelet volume

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

AGED; ARTICLE; BLOOD CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG FUNCTION TEST; MALE; MEAN PLATELET VOLUME; NEUTROPHIL COUNT; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

EID: 84863747852     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.1284     Document Type: Article

References (51)

1. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. Definition: Chapter 1; 1-7.
2. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009; 33: 1165-1185.
3. Vernooy JH, Küçükaycan M, Jacobs JA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med. 2002; 166: 1218-1224. (Pubitemid 35222599)
4. Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med. 1998; 92: 664-667. (Pubitemid 28174838)
5. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996; 51: 819-824. (Pubitemid 26274084)
6. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157: 1418-1422.
7. Donaldson GC, Wilkinson TM, Hurst JR, et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 171: 446-452. (Pubitemid 40444244)
8. Donaldson GC, Seemungal TA, Patel IS, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005; 128: 1995-2004. (Pubitemid 41507533)
9. Hurst JR, Donaldson GC, Perera WR, et al. Utility of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006; 174: 867-874. (Pubitemid 44564786)
10. Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol. 2009; 31: 277-297.
11. Sandhaus LM, Meyer P. How useful are CBC and reticulocyte reports to clinicians? Am J Clin Pathol. 2002; 118: 787-793. (Pubitemid 37046325)
12. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001; 96: 776-781. (Pubitemid 32240730)
13. Milovanovic M, Nilsson E, Järemo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta. 2004; 343: 237-240. (Pubitemid 38534523)
14. Yazici S, Yazici M, Erer B, et al. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets. 2010; 21: 122-125.
15. Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine. 2008; 75: 291-294.
16. Bansal R, Gupta HL, Goel A, Yadav M. Association of increased platelet volume in patients of chronic obstructive pulmonary disease: clinical implications. Journal, Indian Academy of Clinical Medicine. 2002; 3: 169-172.
17. Onder I, Topcu S, Dokmetas HS, et al. Platelet aggregation size and volume in chronic obstructive pulmonary disease. Mater Med Pol. 1997; 29: 11-13.
18. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010. Manage exacerbations: Chapter 5 (Component 4); 64-90.
19. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987; 106: 196-204. (Pubitemid 17009877)
20. Miller MR, Hankinson J, Brusasco V, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-338. (Pubitemid 41079078)
21. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26: 511-522. (Pubitemid 41264217)
22. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993; 16: 5-40.
23. Agustí AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003; 21: 347-360. (Pubitemid 36204553)
24. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59: 574-580. (Pubitemid 38901515)
25. Wedzicha JA, Seemungal TA, MacCallum PK, et al. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost. 2000; 84: 210-215. (Pubitemid 30601465)
26. Dentener MA, Creutzberg EC, Schols AM, et al. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations. Thorax. 2001; 56: 721-726. (Pubitemid 32831700)
27. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996; 7: 157-161. (Pubitemid 26167943)
28. Becchi C, Al Malyan M, Fabbri LP, et al. Mean platelet volume trend in sepsis: is it a useful parameter? Minerva Anestesiol. 2006; 72: 749-756. (Pubitemid 44445754)
29. Machin SJ, Briggs C. Mean platelet volume: a quick easy determinant of thrombotic risk? J Thromb Haemost. 2009; 8: 146-147.
30. Braekkan SK, Mathiesen EB, Njølstad I, et al. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso study. J Thromb Haemost. 2009; 8: 157-162.
31. Thompson CB, Jakubowski JA, Quinn PG, et al. Platelet size and age determine platelet function independently. Blood. 1984; 63: 1372-1375. (Pubitemid 14120383)
32. Varol E, Akcay S, Ozaydin M, et al. Mean platelet volume in patients with coronary artery ectasia. Blood Coagul Fibrinolysis. 2009; 20: 321-324.
33. Cesari F, Marcucci R, Caporale R, et al. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost. 2008; 99: 930-935. (Pubitemid 351705311)
34. Sen N, Tavil Y, Yazici HU, et al. Mean platelet volume in patients with coronary artery ectasia. Med Sci Monit. 2007; 13: 356-359.
35. Keskin S, Guler M, Temeloglu E, et al. Relation between mean platelet volume and risk factors for coronary heart disease. Turkiye Klinikleri Journal of Medical Sciences. 2006; 26: 380-384. (Pubitemid 44638292)
36. De Luca G, Santagostino M, Secco GG, et al. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis. 2009; 206: 292-297.
37. Biljak VR, Pancirov D, Cepelak I, et al. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets. 2011; 22: 466-470.
38. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003; 111: 1805-1812. (Pubitemid 38057722)
39. Malo O, Sauleda J, Busquets X, et al. [Systemic inflammation during exacerbations of Chronic Obstructive Pulmonary Disease]. Arch Bronconeumol. 2002; 38: 172-176. Spanish.
40. Kaczmarek P, Sładek K, Skucha W, et al. The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease. Pol Arch Med Wewn. 2010; 120: 11-17.
41. Fogarty AW, Jones S, Britton JR, et al. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax. 2007; 62: 515-520. (Pubitemid 46910130)
42. de Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006; 27: 902-907. (Pubitemid 44911101)
43. Gan WQ, Man SF, Sin DD. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest. 2005; 127: 558-564. (Pubitemid 40229317)
44. Tantucci C, Donati P, Nicosia F, et al. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir Med. 2008; 102: 613-619.
45. Stevenson NJ, Walker PP, Costello RW, Calverley PM. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 172: 1510-1516. (Pubitemid 43076538)
46. Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med. 2008; 19: 104-108.
47. Skyba P, Kluchova Z, Joppa P, et al. Nutritional status in relation to respiratory impairment and systemic inflammation in patients with acute exacerbations of COPD. Med Sci Monit. 2009; 15: 528-533.
48. Ozhan H, Aydin M, Yazici M, et al. Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets. 2010; 21: 29-32.
49. Yazici M, Kaya A, Kaya Y, et al. Lifestyle modification decreases the mean platelet volume in prehypertensive patients. Platelets. 2009; 20: 58-63.
50. Coban E, Yilmaz A, Sari R. The effect of weight loss on the mean platelet volume in obese patients. Platelets. 2007; 18: 212-216. (Pubitemid 46744121)
51. Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume in patients with obesity. Int J Clin Pract. 2005;59: 981-982.